Recent advances: Gastroenterology

BMJ

Volumn 316, Issue 7125, 1998, Pages 125-

  Barbezat, G O ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; METRONIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; PROTOPORPHYRIN; RANITIDINE BISMUTH CITRATE;

BARRETT ESOPHAGUS; CANCER SCREENING; COLON CANCER; CROHN DISEASE; ENDOSCOPIC SURGERY; GASTROENTEROLOGY; GENE MUTATION; GENETIC SCREENING; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HEMOCHROMATOSIS; MEDICAL INFORMATION; MISSENSE MUTATION; MYCOBACTERIUM PARATUBERCULOSIS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW; STOMACH ACID SECRETION; STOMACH CANCER;

BARRETT ESOPHAGUS; COLONIC NEOPLASMS; CROHN DISEASE; GASTROENTEROLOGY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HEMOCHROMATOSIS; HUMANS; MUTATION;

EID: 0032501669     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.316.7125.125     Document Type: Article

References (40)

1. Haemochromatosis … definite maybe! Nature Genetics 1995;13:375–6.
2. Simon M. Bourel M. Fauchet R. Genetet B. Association of HLA-A3 and HLA-B14 antigens with idiopathic haemochromatosis. Gut 1976;17:332–4.
3. Burt M.J. Smit D.J. Pyper W.R. Powell L.W. Jazwinska E.C. Megabase Y.A. contig and physical map over the haemochromatosis gene region. Genomics 1996;33:153–8.
4. Feder J.N. Gnirke A. Thomas W. Tsuchihashi Z. Ruddy D.A. Basava A. et al. A novel M.H. class l-like gene is mutated in patients with hereditary haemochromatosis. Nature Genetics 1996;13:399–408.
5. Spechler S.J. Goyal R.K. The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. Gastroenterology 1966;110:614–21.
6. Van der Burgh A. Dees J. Hop W.C.J. van Blankenstein M. Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. Gut 1996;39:5–8.
7. Provenzale D. Kemp J.A. Arora S. Wong J.B. A guide for surveillance of patients with Barrett's esophagus. Am J Gastroenterol 1994;89:670–80.
8. Berenson M.M. Johnson T.D. Markowitz N.R. Buchi K.N. Samowitz W.S. Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium. Gastroenterology 1993:104:1686–91.
9. Spechler J.J. Laser photoablation of Barrett's epithelium: burning issues about burning tissues. Gastroenterology 1993;104:1855–8.
10. Overholt B.F. Panjehpour M. Barrett's esophagus: photodynamic therapy for ablation of dysplasia, reduction of specialised mucosa, and treatment of superficial esophageal cancer. Gastrointest Endosc 1995;42:64–70.
11. Regula J. MacRobert A.J. Gorchein A. Buonaccorsi G.A. Thorpe S.M. Spencer G.M. et al. Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX—a pilot study. Gut 1995;36:67–75.
12. Barr H. Shepherd N.A. Dix A. Roberts D.J.H. Tan W.C. Krasner N. Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX Lancet 1996;348:584–5.
13. Harris A.W. Gummett P.A. Walker M.M. Misiewicz J.J. Baron J.H. Relation between gastric acid output, Helicobacter pylori, and gastric metaplasia in the duodenal bulb. Gut 1996;39:513–20.
14. Noach L.A. Rolf T.M. Bosma N.B. Schwartz M.P. Ooosting J. Rauwse A.J. Tytgat G.N.J. Gastric metaplasia and Helicobacter pylori infection. Gut 1993;34:1510–4.
15. Fossati D. Alvisi C. Frego R. Perego M. Luinetti O. Fiocca R. No change in intestinal metaplasia after H pylori eradication. Gut 1996;39 (suppl 2):A104.
16. Atherton J.C. Peek R.M. Tham K.T. Cover T.L. Blaser M.J. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 1997;112:92–9.
17. Bazzoli F. Zagari R.M. Fossi S. Pozzato P. Alampi G. Sottili A.S. et al. Short-term low-dose triple therapy for the eradication of Helicobacter pylori: a randomised, double-blind, controlled study. Gut 1996;39 (suppl 2):A33.
18. Misiewicz J.J. Harris A.W. Bardhan K.D. Levi S. Langworthy H. One week low dose H pylori eradication therapy heals 90% of duodenal ulcers. Gut 1996;39 (suppl 2):A34.
19. Misiewicz J.J. Harris A.W. Bardhan K.D. Levi S. Langworthy H. Over 95% of patients remain H pylori negative 6 months after one week low-dose eradication therapy. Gut 1996;39 (suppl 2):A34.
20. Axon A.T.R. Ireland A. Lancaster Smith M.J. Rooprams P.D. Ranitidine bismuth citrate and clarithromycin twice daily in the eradication of Helicobacter pylori. Aliment Pharmacol Ther 1997;11:81–87.
21. Franzin G. Zamboni G. Savio A. Scarpa A. Capelli P. Mombello A. et al. Gastric MALT low-grade lymphoma: follow-up study after eradication of Helicobacter pylori. Gastroenterology 1996;110:A109.
22. Corthesy-Theulaz I. Porta N. Glauser M. Saraga E. Vaney A.C. Haas R. et al. Oral immunisation with Helicobacter pylori urease B subunit as a treatment against helicobacter infection in mice. Gastroenerology 1995:109:115–121.
23. Kreiss C. Buclin T. Cosma M. Biollaz J. Corthesy-Theulaz I. Porta N. et al. Safety of oral immunisation with recombinant urease in H pylori infected humans. Gastroenterology 1996;110:A162.
24. Hardcastle J.D. Chamberlain J.O. Robinson M.H.E. Moss S.M. Amar S.S. Balfour T.W. et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472–7.
25. Kronborg O. Fenger C. Olsen J. Jorgensen O.D. Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467–71.
26. Mandel J.S. Bond J.H. Church J.R. Snover D.C. Bradley G.M. Schuman L.M. et al. Reducing mortality from colorectal cancer by screening for faecal occult blood. N Engl J Med 1993;328:1365–71.
27. Lynch H.T. Smyrk T.C. Watson P. Lanspa S.J. Lynch J.F. Lynch P.M. et al. Genetics, natural history, tumor spectrum and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 1993;104:1535–49.
28. Mulcahy H.E. Farthing M.J.G. O'Donoghue D.P. Screening for asymptomatic colorectal cancer. BMJ 1997;314:285–91.
29. Wakefeld A.T. Ekbom A. Dhillon A.R. Pittilo R.M. Pounder R.E. Crohn's disease: pathogenesis and persistent measles virus infection. Gastroenterology 1995;108:911–6.
30. Chadwick N. Bruce I. Davies M. Pounder R. Wakefield A. Hybrid capture followed by RT-PCR does not detect measles R.N. in intestinal tissue. Gastroenterology 1997;112:A946.
31. Morgan K.L. Johne's and Crohn's: chronic inflammatory bowel diseases of infectious aetiology? Lancet 1987;2:1017–9.
32. Swift G.L. Srivastava E.D. Stone R. Pullan R.D. Newcombe R.G. Rhodes J. et al. Controlled trial of anti-tuberculous chemotherapy for two years in Crohn's disease. Gut 1994;35:363–8.
33. Mishina D. Katsel P. Brown S.T. Gilberts E.C.A.M. Greenstein R.J. On the etiology of Crohn disease. Proc Natl Acad Sci USA. 1996;93:9816–20.
34. Millar D. Ford J. Sanderson J. Withey S. Tizard M. Doran et al. IS900 P.C. to detect Mycobacterium paratuberculosis in retail supplies of whole pasteurised cows' milk in England and Wales. Appl Environ Microbiol 1996;62:3446–52.
35. Suenaga K. Yokoyama Y. Okazaki K. Yamamoto Y. Mycobacteria in the intestine of Japanese patients with inflammatory bowel disease. Am J Gastroenterol 1995;90:76–80.
36. Rowbotham D.S. Mapstone N.P. Trejdosiewicz L.K. Howdle P.D. Quirke P. Mycobacterium paratuberculosis D.N. not detected in Crohn's disease tissue by fluorescent polymerase chain reaction. Gut 1995;37:660–7.
37. Graham D.Y. Al-Assi M.T. Robinson M. Prolonged remission in Crohn's disease following therapy for Mycobacterium paratuberculosis infection. Gastroenterology 1995;108:A826.
38. Rubin P.H. Chapman M.L. Scherl E. Sachar D.B. Stamaty C. Present D.H. Clarithromycin in active Crohn's disease (CD): preliminary results of open label pilot study. Gastroenterology 1996;110:A1005.
39. Gui G.P.H. Thomas P.R.S. Tizard M.L.V. Lake J. Sanderson J.D. Hermon-Taylor J. Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics. Br Soc Antimicrob Chemother 1997;39:393–400.
40. Liu Y. van Kruiningen J. West A.B. Cartun R.W. Cortot A. Columbel J.-F. Immunocytochemical evidence of lysteria, Eschericia coli, and streptococcus antigens in Crohn's disease. Gastroenterology 1995;108:1396–404.